Fagan Associates’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-22,510
Closed -$717K 99
2016
Q3
$717K Buy
22,510
+5,325
+31% +$202K 0.44% 57
2016
Q2
$687K Buy
+17,185
New +$636K 0.44% 58
2016
Q1
Sell
-9,225
Closed -$286K 91
2015
Q4
$286K Sell
9,225
-7,525
-45% -$223K 0.19% 84
2015
Q3
$503K Sell
16,750
-21,620
-56% -$713K 0.37% 66
2015
Q2
$1.21M Buy
38,370
+4,620
+14% +$121K 0.81% 40
2015
Q1
$779K Buy
33,750
+20,300
+151% +$420K 0.58% 54
2014
Q4
$264K Buy
+13,450
New +$231K 0.21% 79

Other funds holding AMN

Fagan Associates's AMN Position: Q4 2016 in Review

Fagan Associates sold out of AMN Healthcare (AMN) in Q4 2016, closing a stake of 22,510 shares — an estimated $717K sold.

Fagan Associates first reported a position in AMN in Q4 2014 and held it in 7 quarters. The position peaked at $1.21M in Q2 2015. 273 funds tracked by Wall St. Rank hold AMN as of Q4 2016.

  • Fagan Associates reported no remaining AMN Healthcare position as of Q4 2016 after selling out during the quarter.
  • Fagan Associates sold 22,510 AMN Healthcare shares in Q4 2016, an estimated $717K.
  • Fagan Associates first reported a position in AMN Healthcare in Q4 2014 and held it in 7 quarters.
  • Fagan Associates's AMN Healthcare position peaked at $1.21M in Q2 2015.
  • 273 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2016.

Based on Fagan Associates's 13F filing for Q4 2016, filed 2 Feb 2017.